Objective: The results of diagnostic testing following a comprehensive screening conducted outside of Japan are difficult to obtain and may influence diagnostic test participation rates. This study aimed to clarify the impact of this phenomenon.
Methods: We surveyed 8,504 participants who underwent comprehensive screening in 2018, including 210 (2.5%) participants living abroad. We examined the international participants included in the total number of screening tests and those who required a diagnostic test. Further, we investigated the diagnostic test participation rate among international participants.
Results: The percentages of international participants receiving screening tests and requiring diagnostic tests were 6.3% (106/1,686) and 7.1% (12/170, including those requiring lesion resection), respectively, for screening colonoscopy; 2.8% (68/2,414) and 6.5% (3/46), respectively, for breast cancer screening; and 6.1% (114/1,881) and 4.7% (5/107), respectively, for the prostate-specific antigen test. The diagnostic test participation rates for those identified as “Japanese participants” and “international participants” and for the overall sample were 91.8% (145/158), 16.7% (2/12), and 86.5% (147/170), respectively, for screening colonoscopy; 93.0% (40/43), 0.0% (0/3), and 87.0% (40/46), respectively, for breast cancer screening; and 78.4% (80/102), 0.0% (0/5), 74.8% (80/107), respectively, for the prostate-specific antigen test. There was a significant difference in the diagnostic test participation rate between Japanese and international participants in all three tests (p<0.001, p=0.01, p<0.001). The percentage of international participants who could not be counted as participating in a diagnostic test was 43.5% (10/23) for screening colonoscopy, 50.0% (3/6) for breast cancer screening, and 18.5% (5/27) for the prostate-specific antigen test.
Conclusion: The failure to track diagnostic test participation of international participants contributes to the decline in overall diagnostic test participation in Japan. Measures are required to determine the status of the diagnostic test participation among international participants.
View full abstract